As the field of oncology continues to advance, understanding the intricate dynamics of the tumor microenvironment (TME) has become a critical area of focus. On September 1, 2026, at 10:00 AM EDT, Creative Biolabs will host an exclusive webinar titled "Modeling T Cell Dysfunction in Tumor Microenvironments," featuring keynote speaker Greg M. Delgoffe, Ph.D., Professor of Immunology at the University of Pittsburgh and Director of the Tumor Microenvironment Center at the UPMC Hillman Cancer Center.
The TME is a complex ecosystem where cancer cells, immune cells, and various metabolites interact. As tumors progress, they establish a metabolically challenging environment characterized by nutrient depletion and the accumulation of immunosuppressive byproducts. These metabolic pressures impair immune cell function, leading to T cell dysfunction, immune evasion, and ultimately, a reduced response to standard cancer immunotherapies. This webinar aims to shed light on these mechanisms and explore innovative approaches to modeling the TME in preclinical research.
Traditional models often fail to capture the nuanced interactions between tumor metabolism and immune regulation. By utilizing advanced preclinical testing services and robust in vivo and in vitro models, researchers can better replicate these metabolic stress conditions. These advanced systems provide valuable tools to investigate immune suppression and therapeutic responses under physiologically relevant conditions, offering a more accurate representation of the TME.
"Understanding how metabolic conditions within tumors influence immune-cell behavior is increasingly important in immuno-oncology," said a senior scientific director at Creative Biolabs. "Dr. Delgoffe's work provides an important perspective on how researchers can model these conditions and investigate target discovery and validation."
The webinar will cover several key topics, including how tumor metabolic environments contribute to immune suppression and T cell exhaustion, strategies for modeling TME conditions in preclinical research systems, the mechanisms underlying T cell exhaustion and how nutrient depletion influences T cell function, and how immunometabolism insights can guide therapeutic strategies to enhance cancer immunotherapy. These insights are crucial for researchers and professionals in cancer immunology, pharmaceuticals, and biotechnology, as they seek to develop more effective treatments.
This webinar is particularly relevant for cancer immunology researchers, pharmaceutical and biotechnology professionals, and R&D teams dedicated to oncology drug discovery. By attending, participants will gain a deeper understanding of the challenges posed by the TME and the latest modeling techniques to address them.
For webinar details and registration, please visit the official registration page. This event represents a significant opportunity for the scientific community to engage with leading experts and advance the fight against cancer through improved understanding of the tumor microenvironment.
